Abstract
The production of gamma interferon (IFN) by mononuclear cells (MNC) from patients with exacerbating/remitting multiple sclerosis (MS) and controls was evaluated. After 3 days of culture with concanavalin A, the amount of gamma IFN in supernatant fluids was determined by radioimmunoassay. MNC from MS patients produced significantly (P<0.001) more gamma IFN than MNC from either normal controls or patients with other neurologic diseases. Levels of gamma IFN in the serum and CSF were also measured. Despite the relative absence of gamma IFN in serum (4 positive of 30), all CSF samples tested had low, but detectable, levels of gamma IFN (0.3 to 1.4 U/ml). These studies suggest that some of the autoimmune features and immunologic abnormalities in MS may be related to elevated gamma IFN production.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Steeg PS, Johnson HM, Oppenheim JJ: Regulation of murine macrophage Ia antigen expression by products of activated spleen cells. J Exp Med 152:1248–1254, 1980
Bashan TY, Merigan TC: Recombinant gamma interferon increases HLA-DR synthesis and expression. J Immunol 130:1492–1494, 1983
Leibson HJ, Gefter M, Zlotnik A, Marrack P, Kappler JW: Role of gamma interferon in antibody-producing responses. Nature 309:799–801, 1984
Sidman CL, Marshall JD, Shultz LD, Gray PW, Johnson HM: Gamma interferon is one of several direct B-cell maturing lymphokines. Nature 309:801–804, 1984
Nathan CF, Prendergast TJ, Weibe ME,et al. Activation of human macrophages—comparison to other cytokines with interferon gamma. J Exp Med 160:600–605, 1984
Schultz RM, Kleinschmidt WJ: Functional identity between murine gamma interferon and macrophage activating factor. Nature 305:239–240, 1983
Vogel SN, Weedon LL, Moore RN, Rosenstreich DL: Correction of defective macrophage differentiation in C3H/HeJ mice by an interferon-like molecule. J Immunol 128:380–387, 1982
Catalona WJ, Ratliff JL, McCool RE: Gamma interferon induced byS. aureus protein A augments natural killing and ADCC. Nature 291:77–79, 1981
Goust JM, Hogan EL, Arnaud P: Abnormal regulation of IgG production in multiple sclerosis. Neurology 32:228–234, 1982
Goust JM, Hoffman PM, Pryjma J, Hogan EL, Fudenberg HH: Defective immunoregulation in multiple sclerosis. Ann Neurol 8:526–533, 1980
Link H: Oligoclonal immunoglobulin G in multiple sclerosis brain. J Neurol Sci 16:103–114, 1972
Johnson KP, Nelson BJ: Multiple sclerosis: Diagnostic usefulness of cerebrospinal fluid. Ann Neurol 2:425–431, 1977
Antel JP, Arnason BGW, Medof ME: Suppressor cell function in multiple sclerosis: Correlation with clinical disease activity. Ann Neurol 5:338–342, 1979
Levitt D, Griffin NB, Egan ML: Mitogen-induced plasma cell differentiation in patients with multiple sclerosis. J Immunol 124:2117–2121, 1980
Boyum A: Isolation of lymphocytes, granulocytes, and macrophages. Scand J Immunol 5(Suppl 5):9, 1976
Hirsch RL, Griffin DE, Johnson RT,et al. Cellular immune responses during complicated and uncomplicated measles virus infections of man. Clin Immunol Immunopathol 31:1–12, 1984
Chang TW, McKinney S, Liu V, Kung PC, Vilcek J, Le J: Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma interferon. Proc Natl Acad Sci 81:5219–5222, 1984
Trinchieri G, Matsumoto-Kobayashi M, Clark SC, Seehra J, London L, Perussia B: Response of resting human peripheral blood natural killer cells to interleukin 2. J Exp Med 160:1147–1169, 1984
Kashara T, Hooks JJ, Dougherty SF, Oppenheim JJ: Interleukin 2-mediated immune interferon (gamma) production by human T-cells and T-cell subsets. J Immunol 130:1784–1789, 1983
von Wussow P, Platsoucas CD, Wiranowska-Stewart M, Stewart WE: Human gamma interferon production by leukocytes induced with monoclonal antibodies recognizing T-cells. J Immunol 127:1197–1200, 1981
Hirsch RL, Johnson KP: The effect of recombinant alpha 2 interferon on defective natural killer cell activity in multiple sclerosis. Neurology 35:597–601, 1985
Merrill J, Jondal M, Seely J, Ullberg M, Siden A: Decreased natural killing in patients with multiple sclerosis: An analysis at the level of the single effector cell in the peripheral blood and cerebrospinal fluid in relation to the activity of the disease. Clin Exp Immunol 47:419–430, 1982
Neighbor PA, Grayzel AI, Miller AE: Endogenous and interferon augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro: Studies of patients with multiple sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. Clin Exp Immunol 49:11–21, 1982
Vervliet G, Claeys H, VanHaver H,et al. Interferon production and natural killer cell activity in leukocyte cultures from multiple sclerosis patients. J Neurol Sci 60:137–150, 1983
Neighbor PA, Miller AE, Bloom BR: Interferon responses of leukocytes in multiple sclerosis. Neurology 31:561–566, 1981
Merrill JE, Mohlstrom C, Uittenbogaart C, Kermani-Arab V, Ellison GW, Myers LW: Response to and production of interleukin 2 by peripheral blood and cerebrospinal fluid lymphocytes of patients with multiple sclerosis. J Immunol 133:1931–1937, 1984
Wong GHW, Bartlett PF, Clark-Lewis I, McKimm-Breschkin JL, Schrader JW: Interferon gamma induces the expression of H-2 and Ia antigens on brain cells. J Neuroimmunol 7:255–278, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hirsch, R.L., Panitch, H.S. & Johnson, K.P. Lymphocytes from multiple sclerosis patients produce elevated levels of gamma interferonin vitro . J Clin Immunol 5, 386–389 (1985). https://doi.org/10.1007/BF00915335
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00915335